← ireadpaper · 顶刊中的公共政策研究

多方参与的保险

Insurance with Multiple Actors
NBER Working Papers · 2026 · [{"name": "Jason Abaluck", "affiliation": []}, {"name": "Oren Sarig", "affiliation": []}, {"name": "Jintaek Song", "affiliation": []}]

中文摘要

我们分析社会规划者型保险人如何在消费者与企业(例如患者与医生,或司机与汽车修理工)之间分摊成本分担。在没有缔约摩擦的情况下,企业成本分担可以替代消费者成本分担,但“就诊共付额”除外。最优企业合同取决于消费者成本分担与企业成本分担之间的边际替代率。对于 Medicare 医生服务,预先向医生支付更多、但随着支出增加而支付更少,可同时降低患者和医疗服务提供者的风险;在我们的校准中,由此产生的净收益是消除 Medigap 外部性所获收益的两倍。对于处方药,1 美元的医生文书工作成本所产生的影响,是 1 美元消费者成本分担影响的 45 至 110 倍。

Abstract

We analyze how social-planner insurers split cost-sharing between consumers and firms (e.g. patients and doctors, or drivers and car mechanics). With no contracting frictions, firm cost-sharing can replace consumer cost-sharing other than “visit copays.” Optimal firm contracts depend on the marginal rate of substitution between consumer and firm cost-sharing. For Medicare physician services, paying physicians more up front but less as spending increases reduces risk for both patients and providers; in our calibration, net benefits are twice those from eliminating Medigap externality. For prescription drugs, a dollar of physician paperwork costs is 45–110 times more impactful than a dollar of consumer cost-sharing.
在 ireadpaper 查看全部 →